Skip to content

Effect of vitamin d injection supplements on foot ulcer status  in type II diabetic

Comparison effect of two different doses of vitamin d injection supplements on foot ulcer status  in type II diabetic patients with vitamin d deficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015041321740N1
Enrollment
50
Registered
2015-05-16
Start date
2015-03-17
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot ulcer. Diabetic ulcer

Interventions

Intervention 1: GroupA: cure with 300000IU Vit D3. Intervention 2: GroupB: cure with 150000IU Vit D3.
Treatment - Drugs
GroupA: cure with 300000IU Vit D3
GroupB: cure with 150000IU Vit D3

Sponsors

Shahid Sadoughi University of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: patients with diabetic foot ulcers; Exclusion criteria: pregnancy; presence of associated autoimmune disease; use of anti convulsants (which alter the metabolism of vitamin D); concomitant osteomyelitis; low blood pressure; use of antibiotic in recently month; skin tumors on venous ulcers and/or lymphedema; ulcers in legs of other cause than venous insufficiency; patients with renal insufficiency; paresthesias of lower limbs and the need for surgical debridement.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Foot ulcers scale patients. Timepoint: Before and after interventuon. Method of measurement: With Auto cad 2010.

Secondary

MeasureTime frame
Serum 25(OH)D3. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( ng/dl).;FBS. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( mg/dl).;Serum CRP. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( mg/l).;Serum WBC. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( micro/l).;Serum ESR. Timepoint: Before and after interventin(after 4 week). Method of measurement: With kit ( mm/hr).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Haratian

Hamedan University of Medical Sciences and Health Services

Haratianmohsen@yahoo.com+98 81 3622 2958

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026